" class="no-js "lang="en-US"> Artificial Intelligence Archives - Medtech Alert
Sunday, March 03, 2024

Sort by:

Date

Top Post

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments

Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]

First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States

Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedic surgery, […]

Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer

Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated […]

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development

CytoReason today announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence […]

Biolojic Design Appoints Ronald Herbst, Ph.D., as Chief Scientific Officer

Biolojic Design, a pioneer in the use of artificial intelligence (AI) in antibody design, today announced […]

Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence

Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, […]

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm (www.Debiopharm.com), announced today […]

BIOTRONIK Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions

BIOTRONIK announced today its partnership with AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and […]

Verseon Gains European Patent Protection for Potential Sight and Life-Saving Treatments

Verseon is pleased to announce that the European Patent Office has granted intellectual property protection […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more